Acadian Asset Management’s ImmuCell ICCC Stock Holding History

Acadian Asset Management’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,372	Closed	-$12K	–	1738
2017 Q4	$12K	Buy	+1,372	New	+$11.2K	﹤0.01%	1408
2016 Q4	–	Sell	-1,923	Closed	-$15K	–	1694
2016 Q3	$15K	Hold	1,923	–	–	﹤0.01%	1184
2016 Q2	$13K	Hold	1,923	–	–	﹤0.01%	1179
2016 Q1	$13K	Buy	+1,923	New	+$12.8K	﹤0.01%	1147

Other funds holding ICCC

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SRC

Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

EFS

Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Acadian Asset Management's ICCC Position: Q1 2018 in Review

Acadian Asset Management sold out of ImmuCell (ICCC) in Q1 2018, closing a stake of 1,372 shares — an estimated $12K sold.

Acadian Asset Management first reported a position in ICCC in Q1 2016 and held it in 4 quarters. The position peaked at $15K in Q3 2016. 16 funds tracked by Wall St. Rank hold ICCC as of Q1 2018.

Acadian Asset Management reported no remaining ImmuCell position as of Q1 2018 after selling out during the quarter.
Acadian Asset Management sold 1,372 ImmuCell shares in Q1 2018, an estimated $12K.
Acadian Asset Management first reported a position in ImmuCell in Q1 2016 and held it in 4 quarters.
Acadian Asset Management's ImmuCell position peaked at $15K in Q3 2016.
16 funds tracked by Wall St. Rank held ImmuCell as of Q1 2018.

Based on Acadian Asset Management's 13F filing for Q1 2018, filed 12 Apr 2018.